Lakefront Biotherapeutics NV (LKFT)
NASDAQ: LKFT · Real-Time Price · USD
29.05
+0.11 (0.38%)
At close: Jun 23, 2026, 4:00 PM EDT
29.49
+0.44 (1.51%)
After-hours: Jun 23, 2026, 5:45 PM EDT

LKFT Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, LKFT stock has a consensus rating of "Sell" and an average price target of $23.11. The average 1-year stock price forecast is 20.45% lower than the current stock price, while the lowest is $18.81 (-35.25%) and the highest is $27.42 (-5.61%).

Price Target: $23.11 (-20.45%)
Analyst Consensus: Sell
TargetLowAverageMedianHigh
Price$18.81$23.11$23.11$27.42
Change-35.25%-20.45%-20.45%-5.61%
* Price targets were last updated on May 13, 2026.

Analyst Ratings

The average analyst rating for LKFT stock is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.

Recommendation Trends

RatingDec '25Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy000000
Buy000000
Hold333333
Sell100000
Strong Sell110011
Total543344

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
RBC Capital
RBC Capital
Hold
Maintains
$28
HoldMaintains$28-3.61%May 13, 2026
Morgan Stanley
Morgan Stanley
Sell
Maintains
$22
SellMaintains$22-24.27%Mar 16, 2026

Financial Forecast

Revenue This Year
150.46M
from 1.11B
Decreased by -86.47%
Revenue Next Year
145.26M
from 150.46M
Decreased by -3.46%
EPS This Year
-2.87
from 10.21
EPS Next Year
-4.01
from -2.87
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
234.38M241.25M239.72M275.65M1.11B150.46M
Revenue Growth
-50.97%2.93%-0.63%14.99%303.50%-86.47%
Gross Profit
-86.12M-28.55M-1.57M-94.67M623.09M135.37M
Gross Margin
-36.74%-11.83%-0.65%-34.35%56.02%89.97%
Operating Income
-171.57M-131.06M-85.11M-187.10M535.28M-362.81M
Net Income
-103.23M-217.99M211.70M74.08M320.88M-260.74M
EPS
----10.21-2.87
Free Cash Flow
-119.32M-23.64M-119.36M-274.43M344.64M-581.00M
No. Analysts
-----8
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.

Revenue Forecast

Revenue202620272028
High299.3M
Avg150.5M
Low20.1M

Revenue Growth

Revenue Growth202620272028
High
-73.1%
Avg
-86.5%
Low
-98.2%

EPS Forecast

EPS202620272028
High-2.68
Avg-2.87
Low-3.05

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-